Biocon Limited has informed the Exchange regarding a press release dated December 23, 2025, titled "Biocon Limited signs out-licensing agreement with Ajanta to market Semaglutide in 26 countries".
Biocon Limited has informed the Exchange regarding a press release dated December 23, 2025, titled "Biocon Limited signs out-licensing agreement with Ajanta to market Semaglutide in 26 countries".